Cancer cells arise and progress due to accumulation of genetic and epigenetic alterations that contribute to cancer phenotypes. One potential cause of these alterations are DNA sequences that are ?difficult-to-replicate? (DTR) and act as an endogenous source of replication stress. Across the genome there are two major classes of mutually overlapping DTR sequences, including mini-satellites and micro-satellites in the centromere regions and G-quadruplexes (G4s) in the telomeres. Such secondary structures formed in DTRs, if not properly resolved, may block DNA replication fork movement and lead to genome instability. However, cells have developed mechanisms to resolve these barriers for efficient and faithful DNA replication. The most well-known way to resolve G4 and other secondary structures is unwinding the structure through DNA helicases. During the last funding period, we elucidated that the nuclease/helicase DNA2 facilitates DNA replication at DTR sequences. In our preliminary studies, we showed that the DNA mismatch repair protein MSH2, a component of the MutS? complex, binds to both G4s and DNA2 and strongly stimulates DNA2 to cleave G4 structures. Radiation, elimination of DNA2 or MSH2, or lack of histone H1c ubiquitination cause G4 accumulation. Therefore, we hypothesize that: 1) DNA2 in complex with MutS? excises and repairs G4 structures to facilitate DNA replication through DTRs; 2) ubiquitinated H1c recruits the DNA2/MutS? complex onto G4-bearing DNA ends at double- strand breaks (DSBs) for homology-directed DNA repair (HDR) of DSBs; and 3) gene mutations that impair G4 resolution processes sensitize individuals to chemicals that induce or stabilize G4 structures, leading to genome rearrangements and cancer initiation. We propose to define the important molecular aspects of the G4 excision pathways during DNA replication or DSB repair. Because G4s are implicated as chromosome structural elements and epigenetic motifs that regulate gene expression, G4 excision must be tightly controlled. It is important to elucidate how the DNA2/MutS? is signaled to be recruited to the G4 structure for excision repair. We will define how H1c ubiquitination mediated by ubiquitin E3 ligases ITCH or RNF8 induces DNA2/MutS? to cleave G4 structures during DNA replication and DSB repair. Moreover, a large number of environmentally contaminating compounds (ECCs) can specifically bind to G4 structures and alter the dynamics of G4 resolution. We expect that once genetic mutations impair a G4 resolution pathway, a G4 stabilizer can act synergistically to cause DNA replication stresses, DSBs, and genome rearrangements. Therefore, we will determine if combined genetic and environmental factors that inhibit proper G4 resolution/repair show synergy in promoting genome instability and cancer initiation. Our comprehensive analyses will define the pathway for G4 excision in S phase and during DNA DSB repair via HDR, and will provide evidence that G4-stabilizing ECCs lower the cancer threshold, particularly for individuals with defects in DNA2-mediated G4 and other secondary structure resolution pathways.

Public Health Relevance

DNA sequences can form structures that are ?difficult-to-replicate,? which can serve as barriers to DNA replication and repair and lead to genome instability and cancer. Our proposal is designed to characterize the role of DNA2/MutS? complex in overcoming specific difficult-to-replicate structures, called G-quadruplexes, during DNA replication or repair. Our results will define the cellular pathways and molecular mechanisms involved in overcoming G-quadruplexes, will affirm that individuals with defects in these pathways are more susceptible to cancer, and will provide a solid foundation for new cancer treatment regimens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA085344-21
Application #
9913472
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
1999-07-01
Project End
2024-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
21
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Beckman Research Institute/City of Hope
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Li, Zhengke; Liu, Bochao; Jin, Weiwei et al. (2018) hDNA2 nuclease/helicase promotes centromeric DNA replication and genome stability. EMBO J 37:
Xu, Xiaoliang L; Li, Zhengke; Liu, Aihong et al. (2017) SKP2 Activation by Thyroid Hormone Receptor ?2 Bypasses Rb-Dependent Proliferation in Rb-Deficient Cells. Cancer Res 77:6838-6850
Sun, H; He, L; Wu, H et al. (2017) The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation. Oncogene 36:194-207
Zheng, Li; Jia, Jia; Dai, Huifang et al. (2017) Triptolide-Assisted Phosphorylation of p53 Suppresses Inflammation-Induced NF-?B Survival Pathways in Cancer Cells. Mol Cell Biol 37:
Chu, Fong-Fong; Esworthy, R Steven; Doroshow, James H et al. (2017) Deficiency in Duox2 activity alleviates ileitis in GPx1- and GPx2-knockout mice without affecting apoptosis incidence in the crypt epithelium. Redox Biol 11:144-156
Ray Chaudhuri, Arnab; Callen, Elsa; Ding, Xia et al. (2016) Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature 535:382-7
Zhang, Shirong; Wu, Kan; Feng, Jianguo et al. (2016) Epigenetic therapy potential of suberoylanilide hydroxamic acid on invasive human non-small cell lung cancer cells. Oncotarget 7:68768-68780
Chu, Fong-Fong; Esworthy, R Steven; Doroshow, James H et al. (2016) NADPH oxidase-1 deficiency offers little protection in Salmonella typhimurium-induced typhlitis in mice. World J Gastroenterol 22:10158-10165
Pan, Xiao; Cang, Xiaohui; Dan, Songsong et al. (2016) Site-specific Disruption of the Oct4/Sox2 Protein Interaction Reveals Coordinated Mesendodermal Differentiation and the Epithelial-Mesenchymal Transition. J Biol Chem 291:18353-69
Liu, Wenpeng; Zhou, Mian; Li, Zhengke et al. (2016) A Selective Small Molecule DNA2 Inhibitor for Sensitization of Human Cancer Cells to Chemotherapy. EBioMedicine 6:73-86

Showing the most recent 10 out of 46 publications